Adaptive Capital Partners is a Singapore-based, early-stage venture capital firm established in 2022. It invests in high-conviction, technology-driven companies with a focus on HealthTech, Life Sciences, and deep tech across Southeast Asia.
40% of their portfolio is in Healthcare. Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (60% of deals). Average disclosed round size is $25.1M (across 7 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Jack Perkins
Managing Director
David Liow
Partner
Kar Yew Lee
Investment Associate
Anusha Nair Sredharan
Senior Investment Manager
Guan Yen Liew
Venture Capital
Aaron Gill
VC fund
Rou Phuah
Investments
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Oxford Quantum Circuits | Series C | — | Jun 2026 |
 Respiree Pte Ltd | Series A | — | Feb 2026 |
 Oxford Quantum Circuits | Series C | — | Jan 2026 |
| Respiree Pte Ltd | Series A | $11.6M | Jul 2025 |
| Respiree Pte Ltd | Series A | $11.6M | Jan 2025 |
 Biorithm | Series A | $3.5M | Dec 2023 |
| Oxford Quantum Circuits | Series C | $100M | Nov 2023 |
 Aktivo Labs | Series A | $10M | Jan 2022 |
| IIzumi Finance | Series A | $22M | Jan 2021 |
| AAOA | Seed | $17M | — |
Top Co-Investors
Last updated: 20 October 2026